Literature DB >> 2007521

[Documentation and assessment of adverse drug effects with ofloxacin as an example].

B Esch1, N Paeschke, W Christ, G Kreutz.   

Abstract

A systematical and comprehensive evaluation of all reports on adverse drug reactions ascribed to ofloxacin since this antibiotic was launched (1985) until October 1988 shows that rare and severe adverse drug reactions are more often reported spontaneously than in the course of clinical trials. In particular, severe reductions of white blood cell counts, shock and shock fragments, and impairment of sensory organs and renal functions have for the first time been detected by spontaneous case reports. The results demonstrate exemplarily the potency of the spontaneous reporting system as superior to that of clinical trials in providing information on rare adverse drug reactions.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2007521     DOI: 10.1007/bf01644727

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  6 in total

1.  The clinical evaluation of antibacterial drugs. Report of a Working Party of the British Society of Antimicrobial Chemotherapy.

Authors: 
Journal:  J Antimicrob Chemother       Date:  1989-02       Impact factor: 5.790

2.  [Comparative clinical study of ofloxacin and cefaclor in bacterial bronchitis].

Authors:  I Fujimori; Y Kobayashi; M Obana; A Saito; M Tomizawa; I Nakayama; Y Hiraga; K Kikuchi; A Yamamoto; K Takebe
Journal:  Kansenshogaku Zasshi       Date:  1984-09

3.  [Comparative clinical study of DL-8280 and cefaclor for suppurative skin and soft tissue infections by a double-blind method].

Authors:  K Fujita; M Nakano; E Nonami; T Shishiba; M Katsumata; N Horie; R Watanabe; A Kukita; S Watanabe; T Someya
Journal:  Kansenshogaku Zasshi       Date:  1984-09

4.  Side effects of ofloxacin in clinical trials and in postmarketing surveillance.

Authors:  G Jüngst; R Mohr
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 5.  Ofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  J P Monk; D M Campoli-Richards
Journal:  Drugs       Date:  1987-04       Impact factor: 9.546

6.  [Comparative studies of DL-8280 and pipemidic acid in complicated urinary tract infections by double-blind method].

Authors:  H Kishi; H Nito; I Saito; Y Nishimura; T Niijima; H Ohmori; H Tanaka; Y Fujita; K Deguchi; N Ogawa
Journal:  Hinyokika Kiyo       Date:  1984-09
  6 in total
  1 in total

Review 1.  Postmarketing surveillance of quinolones, 1990 to 1992.

Authors:  P Davey; T McDonald
Journal:  Drugs       Date:  1993       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.